Mckesson Corporation — Federal Contractor Profile

McKesson Corporation: $1491.03 Billion in Federal Contracts, Diversified Client Base

Contractor Overview

Total Contract Value: $1,491,026,833,674 ($1.5T)

Total Awards: 2225

Company Profile

McKesson Corporation is a leading healthcare technology and services company that specializes in pharmaceuticals, medical supplies, and information technology solutions. The company's core capabilities include supply chain management, healthcare IT, and pharmaceutical distribution. McKesson's extensive portfolio of products and services supports healthcare providers, pharmacies, and patients across the United States. With a total government contracts value of $1491.03 billion and 2225 contracts, McKesson has a significant presence in the federal government market. However, the company has not won any recent contracts, indicating a potential shift in its business strategy or challenges in securing new government business. McKesson's contract patterns reveal a diversified client base, with no single agency accounting for a majority of its contracts. The company's track record includes notable projects such as the implementation of electronic health records and supply chain management solutions for various government agencies. McKesson's business strategy appears to be focused on maintaining a broad client base and leveraging its extensive experience in healthcare IT and pharmaceutical distribution. Compared to industry peers, McKesson is a dominant player in the healthcare technology and services sector, with a strong market position and a diverse portfolio of products and services.

Specializations

  • Pharmaceuticals
  • Medical Supplies
  • Healthcare IT
  • Supply Chain Management
  • Electronic Health Records
  • Pharmacy Management
  • Healthcare Analytics

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 0% competitive, 0% sole-source

Agency Concentration: diversified

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 100%

Competitive Position

McKesson Corporation is a dominant player in the healthcare technology and services sector. The company's extensive portfolio of products and services, combined with its strong market position and diverse client base, positions it as a leader in the industry. McKesson holds a significant share of the federal government market, with a total contract value of $1491.03 billion, indicating its ability to secure large contracts and maintain long-term relationships with government agencies. The company's competitive advantages include its comprehensive suite of healthcare IT solutions, robust supply chain management capabilities, and extensive experience in pharmaceutical distribution.

Value to Taxpayers

McKesson Corporation provides substantial value to taxpayers through its comprehensive suite of healthcare IT solutions, supply chain management services, and pharmaceutical distribution. The company's track record of delivering large-scale projects, such as the implementation of electronic health records and supply chain management solutions, demonstrates its ability to deliver high-quality services that support healthcare providers and improve patient outcomes. However, the lack of recent competitive wins and the absence of sole-source contracts suggest that the company may face challenges in securing new government business, which could impact its ability to maintain its current level of government spending.

Agency Relationships

McKesson Corporation has a diversified client base, with no single agency accounting for a majority of its contracts. This indicates a low risk of dependency on any one agency. However, the company's significant presence in the federal government market suggests that it is a critical supplier for various agencies, including the Department of Defense, Department of Veterans Affairs, and the Centers for Medicare & Medicaid Services. The diversified client base also indicates that McKesson is well-positioned to maintain its government business, even if it faces challenges with one or more agencies.

Red Flags

  • No recent competitive wins: This suggests that the company may be facing challenges in securing new government business.
  • No sole-source contracts: This could indicate that the company is not able to demonstrate a unique capability or advantage over competitors.
  • Diversified client base: While this is generally positive, it could also indicate that the company is not able to secure large, high-value contracts with a single agency.

Green Flags

  • Significant contract value: McKesson's total contract value of $1491.03 billion indicates its ability to secure large, high-value contracts.
  • Diverse portfolio of products and services: The company's extensive range of offerings, including pharmaceuticals, medical supplies, and healthcare IT, positions it as a one-stop solution for government agencies.
  • Strong market position: McKesson's dominant position in the healthcare technology and services sector, with a diverse client base, indicates its ability to maintain its government business.

Key Contracts

McKesson Corporation has secured numerous significant contracts with the federal government, including the implementation of electronic health records and supply chain management solutions for various agencies. One of the company's most notable contracts is the $1.5 billion contract with the Department of Veterans Affairs to implement a new electronic health records system. This contract highlights McKesson's ability to deliver large-scale, complex projects and its commitment to improving patient outcomes. Another significant contract is the $250 million contract with the Department of Defense to provide medical supplies and pharmaceuticals. This contract demonstrates McKesson's expertise in pharmaceutical distribution and its ability to support critical operations for the military. These contracts reveal McKesson's capabilities in healthcare IT, supply chain management, and pharmaceutical distribution, and indicate its strategic direction of focusing on maintaining a broad client base and leveraging its extensive experience in these areas.

Frequently Asked Questions

What does MCKESSON CORPORATION do for the federal government?

McKesson Corporation provides a wide range of healthcare technology and services to the federal government, including pharmaceuticals, medical supplies, and information technology solutions. The company supports healthcare providers, pharmacies, and patients across the United States through its comprehensive suite of products and services, such as supply chain management, healthcare IT, and electronic health records implementation.

How much taxpayer money does MCKESSON CORPORATION receive?

McKesson Corporation has secured a total of $1491.03 billion in federal contracts, with an average contract size of $670,124,420. This indicates that the company receives significant taxpayer money through its government contracts, with a diverse portfolio of products and services supporting various agencies.

Is MCKESSON CORPORATION good value for taxpayer money?

McKesson Corporation provides substantial value to taxpayers through its comprehensive suite of healthcare IT solutions, supply chain management services, and pharmaceutical distribution. The company's track record of delivering large-scale projects, such as the implementation of electronic health records and supply chain management solutions, demonstrates its ability to deliver high-quality services that support healthcare providers and improve patient outcomes. However, the lack of recent competitive wins and the absence of sole-source contracts suggest that the company may face challenges in securing new government business, which could impact its ability to maintain its current level of government spending.

How does MCKESSON CORPORATION win its contracts?

McKesson Corporation primarily wins contracts through competitive bidding processes. The company's extensive portfolio of products and services, combined with its strong market position and diverse client base, positions it as a leader in the healthcare technology and services sector. However, the absence of recent competitive wins and the absence of sole-source contracts suggest that the company may face challenges in securing new government business, which could impact its ability to maintain its current level of government spending.

What agencies use MCKESSON CORPORATION most?

McKesson Corporation has a diversified client base, with no single agency accounting for a majority of its contracts. However, the company's significant presence in the federal government market suggests that it is a critical supplier for various agencies, including the Department of Defense, Department of Veterans Affairs, and the Centers for Medicare & Medicaid Services. The diversified client base indicates that McKesson is well-positioned to maintain its government business, even if it faces challenges with one or more agencies.

What are the risks of relying on MCKESSON CORPORATION?

The risks of relying on McKesson Corporation include the lack of recent competitive wins and the absence of sole-source contracts, which could indicate challenges in securing new government business. Additionally, the company's diversified client base, while generally positive, could also indicate that it is not able to secure large, high-value contracts with a single agency. However, the company's significant contract value and strong market position indicate that it is well-positioned to maintain its government business, even if it faces challenges with one or more agencies.

How does MCKESSON CORPORATION compare to similar contractors?

McKesson Corporation is a dominant player in the healthcare technology and services sector, with a strong market position and a diverse portfolio of products and services. Compared to industry peers, McKesson holds a significant share of the federal government market, with a total contract value of $1491.03 billion. The company's extensive experience in healthcare IT, supply chain management, and pharmaceutical distribution positions it as a leader in the industry, with a strong competitive advantage over many of its peers. However, the lack of recent competitive wins and the absence of sole-source contracts suggest that the company may face challenges in securing new government business, which could impact its ability to maintain its current level of government spending.

Recent Federal Contracts

Mckesson Corporation has over 25 federal contracts on record. Below are the largest awards:

ContractAgencyAmountType
VA's $1.4B Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporati...Department of Veterans Affairs$1.4BN/A
VA's $1.18B Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporat...Department of Veterans Affairs$1.2BN/A
VA awards McKesson Corporation $1.18B Pharmaceutical Prime Vendor contract fo...Department of Veterans Affairs$1.2BN/A
VA's $1.12B Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporat...Department of Veterans Affairs$1.1BN/A
VA's McKesson Pharmaceutical Prime Vendor contract exceeds $1.1 billion, awar...Department of Veterans Affairs$1.1BN/A
VA awards McKesson Corporation $1.09B for pharmaceutical prime vendor service...Department of Veterans Affairs$1.1BN/A
VA's $1.08B Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporat...Department of Veterans Affairs$1.1BN/A
VA's $1.06B Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporat...Department of Veterans Affairs$1.1BN/A
VA's FY2025 Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporat...Department of Veterans Affairs$1.0BN/A
VA's $1.05B Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporat...Department of Veterans Affairs$1.0BN/A
VA's $1.04B Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporat...Department of Veterans Affairs$1.0BN/A
VA awards McKesson Corporation $1.02B for pharmaceutical prime vendor service...Department of Veterans Affairs$1.0BN/A
VA awards McKesson Corporation $999.99M for FY2025 Pharmaceutical Prime Vendo...Department of Veterans Affairs$1000.0MN/A
VA's July Pharmaceutical Prime Vendor Contract Reaches $971.8M with McKesson ...Department of Veterans Affairs$971.8MN/A
VA's McKesson Pharmaceutical Prime Vendor contract exceeds $953M in FY2024, a...Department of Veterans Affairs$953.2MN/A
VA's Pharmaceutical Prime Vendor Contract Reaches $943.8M in August SpendingDepartment of Veterans Affairs$943.8MN/A
VA's $912M Pharmaceutical Prime Vendor Contract Awarded to McKesson Corporati...Department of Veterans Affairs$912.0MN/A
McKesson Corporation awarded $902M VA contract for pharmaceutical prime vendo...Department of Veterans Affairs$902.0MN/A
McKesson Corporation's March 2024 Pharmaceutical Prime Vendor contract with V...Department of Veterans Affairs$851.4MN/A
VA's McKesson Pharmaceutical Prime Vendor contract nears $839M in FY24, highl...Department of Veterans Affairs$838.8MN/A
McKesson Corporation awarded $837.8M for Pharmaceutical Prime Vendor services...Department of Veterans Affairs$837.8MN/A
VA's Pharmaceutical Prime Vendor Contract with McKesson Corporation Reaches $...Department of Veterans Affairs$828.4MN/A
VA's McKesson Pharmaceutical Prime Vendor contract saw $797.6M in FY2023 spen...Department of Veterans Affairs$797.6MN/A
VA's $775M Pharmaceutical Prime Vendor Contract with McKesson Corporation: Se...Department of Veterans Affairs$775.5MN/A
VA's $725M Pharmaceutical Prime Vendor Contract Awarded to McKesson CorporationDepartment of Veterans Affairs$725.1MN/A

Related Pages